Lynch样综合征的临床与病理特征分析
本研究基于西班牙全国结直肠癌登记数据,纳入160例Lynch样综合征患者,分析其临床、病理及家族史特征。结果显示患者诊断结直肠癌平均年龄55岁,女性66例(41%),11%符合Amsterdam标准,65%符合修订Bethesda标准,24%经通用筛查发现。无论是否有结直肠癌家族史,患者临床、人口学及病理特征均无比例差异。
要点
- Lynch样综合征患者诊断结直肠癌平均年龄55岁,女性占41%。
- 11%符合Amsterdam标准,65%符合修订Bethesda标准,24%经通用筛查发现。
- 无论是否符合Amsterdam/Bethesda标准或经通用筛查发现,临床病理特征无比例差异。
核心结论
- Lynch样综合征患者无论有无结直肠癌家族史,其临床、人口学及病理特征均表现一致。
研究设计与样本
- 基于西班牙全国结直肠癌登记数据,纳入160例Lynch样综合征患者,收集人口学、临床、病理及家族史特征。
主要发现
- 160例Lynch样综合征患者诊断结直肠癌平均年龄55岁,女性66例(41%)。
- 11%符合Amsterdam I和II标准,65%符合修订Bethesda指南标准,24%经通用筛查发现。
- 符合Amsterdam和/或Bethesda标准且有结直肠癌家族史的患者与经通用筛查发现且无结直肠癌家族史的患者,在性别、结肠镜检查指征、免疫组化、病理发现或个人结直肠癌或其他Lynch综合征相关肿瘤史上无比例差异。
关键数值与推荐
- Lynch样综合征定义为:结直肠肿瘤免疫组化显示MSH2、MSH6、PMS2或MLH1缺失,且无BRAF V600E突变(实时PCR检测)和/或MLH1无甲基化(甲基化特异性多重连接依赖探针扩增检测),且MMR基因、BRAF或EPCAM无致病突变(DNA测序检测)。
临床怎么用
- 对于疑似Lynch综合征但无MMR基因致病突变的患者,可考虑Lynch样综合征,其临床病理特征与家族史无关。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Lynch syndrome is characterized by DNA mismatch repair (MMR) deficiency. Some patients with suspected Lynch syndrome have DNA MMR deficiencies but no detectable mutations in genes that encode MMR proteins-this is called Lynch-like syndrome (LLS). There is no consensus on management of patients with LLS. We collected data from a large series of patients with LLS to identify clinical and pathology features. METHODS: We collected data from a nationwide-registry of patients with colorectal cancer (CRC) in Spain. We identified patients whose colorectal tumors had loss of MSH2, MSH6, PMS2, or MLH1 (based on immunohistochemistry), without the mutation encoding V600E in BRAF (detected by real-time PCR), and/or no methylation at MLH1 (determined by methylation-specific multiplex ligation-dependent probe amplification), and no pathogenic mutations in MMR genes, BRAF, or EPCAM (determined by DNA sequencing). These patients were considered to have LLS. We collected data on demographic, clinical, and pathology features and family history of neoplasms. The χ2 test was used to analyze the association between qualitative variables, followed by the Fisher exact test and the Student t test or the Mann-Whitney test for quantitative variables. RESULTS: We identified 160 patients with LLS; their mean age at diagnosis of CRC was 55 years and 66 patients were female (41%). The Amsterdam I and II criteria for Lynch syndrome were fulfilled by 11% of cases and the revised Bethesda guideline criteria by 65% of cases. Of the patients with LLS, 24% were identified in universal screening. There were no proportional differences in sex, indication for colonoscopy, immunohistochemistry, pathology findings, or personal history of CRC or other Lynch syndrome-related tumors between patients who met the Amsterdam and/or Bethesda criteria for Lynch syndrome and patients identified in universal screening for Lynch syndrome, without a family history of CRC. CONCLUSIONS: Patients with LLS have homogeneous clinical, demographic, and pathology characteristics, regardless of family history of CRC.
引用
- Picó MD, Castillejo A, Murcia Ó, et al. Clinical and Pathological Characterization of Lynch-Like Syndrome. Clin Gastroenterol Hepatol. 2019. PMID: 31220642. doi:10.1016/j.cgh.2019.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。